THERESA REHG: Open Payments
NPI 1760907414 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,036 in 47 payments from 22 companies in 2025. Trend: 2023 $536 · 2024 $1,242 · 2025 $1,036
Food & beverage: $1,036
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $144 |
| Insulet Corporation | 3 | $85 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Radius Health, Inc. | 3 | $76 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $71 |
| BETA BIONICS, INC. | 3 | $61 |
| Amgen Inc. | 3 | $58 |
| Sequel Med Tech, LLC | 2 | $52 |
| Tandem Diabetes Care, Inc. | 2 | $45 |
| Abbott Laboratories | 2 | $45 |
Products named: Ozempic, Omnipod, LEQVIO, Tymlos, ISTURISA, iLet Bionic Pancreas, TWIIST, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across MO — which companies pay providers there.
